https://orcid.org/0000-0001-9022-2229
Selected Grants
The Duke University - Duke Cancer Institute National Clinical Trials Network Lead Academic Participating Site (UG1) Support Grant
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2032TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE_BDT)
Clinical TrialPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2025 - 2031A Pragmatic Phase II Trial of Chemotherapy +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Clinical TrialPrincipal Investigator · Awarded by Indiana University · 2025 - 2030I-SPY 2 Trial: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Clinical TrialPrincipal Investigator · Awarded by Quantum Leap Healthcare Collaborative · 2025 - 2030Predicting cancer treatment-related cardiotoxicity by imaging cardiac mechanical stiffness
ResearchPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2025 - 2028A single shot therapy will accelerate the elimination of breast cancer
ResearchResearch Professional · Awarded by United States Army Medical Research Acquisition Activity · 2024 - 2028Cardiovascular Impact of Near-complete Estrogen Deprivation for Breast Cancer
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2024 - 2027NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
ResearchPrincipal Investigator · Awarded by NRG Oncology · 2023 - 2026External Relationships
- Accord BioPharma
- Cancer Expert Now
- Exact Sciences
- RTI International
- WebMD/Medscape
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.